EVROPEYSKIY KONSENSUS PO TERAPII RESPIRATORNOGO DISTRESS-SINDROMA NOVOROZhDENNYKh. PERESMOTR 2013 g. ChTO NOVOGO?
- Authors: Ovsyannikov D.Y.1
-
Affiliations:
- Issue: No 3 (2014)
- Pages: 59-65
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/286636
- ID: 286636
Cite item
Open Access
Access granted
Abstract
In 2013, updated recommendations of the European expert panel of neonatologists under the patronage of the European Association of Perinatal Medicine for respiratory distress syndrome (RDS) in newborns were published. Consensus was designed to overcome the contradictions in relation to perinatal care for newborns with RDS, remaining after development of recommendations 2010. Updated guidelines provide new data from the Cochrane reviews and medical literature as of end of 2012. The new systems of assessing the level of evidence (GRADE) and recommendations were used. The document consistently address the issues of prenatal care, the stabilization of the newborn in the delivery room, surfactant therapy, the additional introduction of oxygen after stabilization of state, noninvasive ventilation, mechanical ventilation strategies and related therapy with caffeine, permissible hypercapnia and postnatal administration of steroids, prevention of sepsis and supportive therapy.
Full Text
References
- EuroNeoStat Annual Report for Very Low Gestational Age Infants 2010. The ENS Project. Hospital de Cruces, Unidad Neonatal 5-D, Plaza de Cruces s/n, 48903 Barakaldo, Spain. Info. euroneonet@euskalnet.net
- Soll R.F. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database Syst. Rev. 2000: CD000511.
- Soll R., Ozek E. Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database Syst. Rev. 2010: CD001079.
- SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network, Carlo W.A., Finer N.N., Walsh M.C., Rich W., Gantz M.G., Laptook A.R., et al: Target ranges of oxygen saturation in extremely preterm infants. N. Engl. J. Med. 2010; 362: 1959-69.
- Stenson B., Brocklehurst P., Tarnow-Mordi W. Increased 36-week survival with high oxygen saturation target in extremely preterm infants. N. Engl. J. Med. 2011; 364: 1680-82.
- Kuppala V.S., Meinzen-Derr J., Morrow A.L., Schibler K.R. Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J. Pediatr. 2011; 159: 720-25.
- Tzialla C., Borghesi A., Perotti G.F., Garofoli F., et al. Use and misuse of antibiotics in the neonatal intensive care unit. J. Matern. Fetal Neonatal Med. 2012; 25(suppl 4): 35-7.
- Sweet D.G., Carnielli V., Greisen G., Hallman M., et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants - 2013 update. Neonatology. 2013; 103: 353-68.
- Sweet D., Bevilacqua G., Carnielli V., Greisen G., et al. Working Group on Prematurity of the World Association of Perinatal Medicine, European Association of Perinatal Medicine: European consensus guidelines on the management of neonatal respiratory distress syndrome. J. Perinat. Med. 2007; 35: 175-86.
- Sweet D.G., Carnielli V., Greisen G., Hallman M., et al. European Association of Perinatal Medicine: European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants - 2010 update. Neonatology. 2010; 97: 402-17.
Supplementary files
